Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28497787.
- Also identified by DOI 10.1038/ncomms15315 and PMC identifier 5437308.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Efforts to manipulate locus-specific histone acetylation to assess their causal role in gene expression and cellular and behavioural phenotypes have been impeded by a lack of experimental tools. The Cas9 nuclease has been adapted to target epigenomic modifications, but a detailed description of the parameters of such synthetic epigenome remodellers is still lacking. Here we describe a Cas9-based histone deacetylase (HDAC) and the design principles required to achieve locus-specific histone deacetylation. We assess its range of activity and specificity, and analyse target gene expression in two different cell types to investigate cellular context-dependent effects. Our findings demonstrate that the chromatin environment is an important element to consider when utilizing this synthetic HDAC.
Medical subject headings
- CRISPR-Cas Systems
- Chromatin
- Histone Deacetylases
- Histones